Geoffrey M.D. Ling - Jun 9, 2021 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (CBIO)

Role
Director
Signature
/s/ Faisal Shawwa, Attorney-in-Fact for Geoffrey Ling
Stock symbol
CBIO
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 09:54 AM
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBIO Common Stock Award $0 +2.71K +20.3% $0.00 16.1K Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBIO Stock Option (Right to Buy) Award $0 +14K $0.00 14K Jun 9, 2021 Common Stock 14K $4.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received in lieu of fees.
F2 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date.